These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 15176917)
21. An analysis of the topography, severity, potential sources of reinforcement, and treatments utilized for skin picking in Prader-Willi syndrome. Hustyi KM; Hammond JL; Rezvani AB; Hall SS Res Dev Disabil; 2013 Sep; 34(9):2890-9. PubMed ID: 23810929 [TBL] [Abstract][Full Text] [Related]
22. Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity. Bays HE; Gadde KM Drugs Today (Barc); 2011 Dec; 47(12):903-14. PubMed ID: 22348915 [TBL] [Abstract][Full Text] [Related]
23. Topiramate for binge-eating disorder associated with obesity. Tata AL; Kockler DR Ann Pharmacother; 2006 Nov; 40(11):1993-7. PubMed ID: 17047134 [TBL] [Abstract][Full Text] [Related]
24. Topiramate and phentermine: a long story... Prescrire Int; 2013 Mar; 22(136):62. PubMed ID: 23593687 [No Abstract] [Full Text] [Related]
25. Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditions. Guille C; Sachs G Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1035-9. PubMed ID: 12452523 [TBL] [Abstract][Full Text] [Related]
27. Continuing weight-loss effect after topiramate discontinuation in obese persons with schizophrenia: a pilot open-label study. Liang CS; Yang FW; Huang SY; Ho PS Pharmacopsychiatry; 2014 Jul; 47(4-5):162-8. PubMed ID: 24936804 [TBL] [Abstract][Full Text] [Related]
28. Specific treatment of Prader-Willi syndrome through cyclical rehabilitation programmes. Grolla E; Andrighetto G; Parmigiani P; Hladnik U; Ferrari G; Bernardelle R; Lago MD; Albarello A; Baschirotto G; Filippi G; Lovato R; Dolcetta D Disabil Rehabil; 2011; 33(19-20):1837-47. PubMed ID: 21269146 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of add-on topiramate therapy in psychiatric patients with weight gain. Cates ME; Feldman JM; Boggs AA; Woolley TW; Whaley NP Ann Pharmacother; 2008 Apr; 42(4):505-10. PubMed ID: 18364406 [TBL] [Abstract][Full Text] [Related]
31. Maladaptive and compulsive behavior in Prader-Willi syndrome: new insights from older adults. Dykens EM Am J Ment Retard; 2004 Mar; 109(2):142-53. PubMed ID: 15000675 [TBL] [Abstract][Full Text] [Related]
32. The use of fluoxetine in an adolescent with Prader-Willi syndrome. Dech B; Budow L J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):298-302. PubMed ID: 2016235 [TBL] [Abstract][Full Text] [Related]
37. Contaminated and unusual food combinations: what do people with Prader-Willi syndrome choose? Dykens EM Ment Retard; 2000 Apr; 38(2):163-71. PubMed ID: 10804706 [TBL] [Abstract][Full Text] [Related]
38. Oral mucosa in children with Prader-Willi syndrome. Olczak-Kowalczyk D; Witt A; Gozdowski D; Ginalska-Malinowska M J Oral Pathol Med; 2011 Nov; 40(10):778-84. PubMed ID: 21457346 [TBL] [Abstract][Full Text] [Related]
39. Use of low-dose topiramate in substance use disorder and bodyweight control. Chiu YH; Lee TH; Shen WW Psychiatry Clin Neurosci; 2007 Dec; 61(6):630-3. PubMed ID: 18081623 [TBL] [Abstract][Full Text] [Related]
40. Morbid obesity in an adolescent with Prader-Willi syndrome. Santos VM; Henrique de Paula F; Osterne EM; Nery NS; Turra TZ Rev Med Chil; 2009 Feb; 137(2):264-8. PubMed ID: 19543650 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]